Keeping Healthcare Stakeholders Informed: A Week in Review of Washington, D.C.’s Health Policy Newsletter

Insights from the May 7, 2024 Holland & Knight Health Dose

The Health Dose newsletter from Holland & Knight is a comprehensive weekly update on legislative and regulatory developments in Washington, D.C. that impact the health sector. The goal of this newsletter is to keep stakeholders informed and up-to-date on the latest happenings in the industry.

This week’s edition covers a wide range of topics, including the FAA Reauthorization, House passage of the Congressional Budget Office Data Sharing Act, and the Senate Committee on Finance’s release of a discussion draft on drug shortages. Additionally, the House Ways and Means Committee is set to mark up legislation to extend telehealth waivers, FDA officials will be appearing before the E&C Subcommittee, and there will be hearings on administrative and regulatory burdens in healthcare in both the House and Senate.

Last week also saw hearings on cyberattacks, Medicaid and LTSS, maternal mortality, workforce diversity, Medicare and Social Security Trustees releasing their annual reports, HHS issuing Cost Sharing FAQs, HHS releasing draft guidance for the Second Cycle of the Medicare Drug Price Negotiation Program, FDA releasing a Laboratory Developed Test Final Rule, DACA Health Coverage Rule being finalized and new appointments to Medicaid Payment Access Commission (MACPAC).

To stay informed about these developments in healthcare policy and regulations

Leave a Reply